Once-taboo ketamine booms for US at-home mental care

By Agence France-Presse

Feb 20, 2022 1:01 pm

WASHINGTON, D.C.: Americans are paying to get a star of the psychedelic medicine movement — ketamine — shipped to them for at-home mental health treatments that are being called both a breakthrough and a gamble.

A pandemic-spurred easing of prescription rules helped fuel a jump in telemedicine offerings of ketamine, an anesthetic that was once a taboo party drug but has become a buzzed-about tool against depression.

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

No special session for trial – Escudero

ICC chief slams US sanctions

525K liters of smuggled diesel seized

Superpower contest spills over to EDSA busway

Better opportunities sought for workers

Court reverses CA on Goldland case

Book on Aquino legacy out soon